Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov 6;16(11):1739.
doi: 10.3390/v16111739.

Acute Hepatitis C: Current Status and Future Perspectives

Massimo Fasano  1 , Francesco Ieva  2 , Marianna Ciarallo  2 , Bruno Caccianotti  2 , Teresa Antonia Santantonio  2
Affiliations
Review

Acute Hepatitis C: Current Status and Future Perspectives

Massimo Fasano et al. Viruses. .

Abstract

The hepatitis C virus (HCV) infection continues to represent a significant public health threat and is a leading cause of liver cirrhosis, liver cancer, and liver-related mortality. The World Health Organization (WHO) has set a goal for 2030: to eliminate HCV infection as a public health threat by reducing new HCV infections by 90% and mortality by 65%. The early phase of HCV infection represents a pivotal point in the evolution of hepatitis C. Despite a favourable course in the majority of patients, approximately 50-70% of individuals with recently acquired hepatitis C will develop a chronic infection, defined as the persistence of viremia for a period exceeding six months. The diagnosis and treatment of a recent HCV infection should facilitate engagement in multidisciplinary care, prevent the development and complications of chronic liver disease, and reduce ongoing transmission in key populations. Therefore, early treatment in the early phase of infection compared with deferring treatment until the chronic infection remains a valid approach in the era of direct antiviral agents (DAAs). This approach is supported by a cost-effectiveness analysis. The aim of this review is to synthesise the existing knowledge on the early phase of hepatitis C virus infection, with a particular focus on the current risk factors, natural history, therapeutic management, and future perspectives.

Keywords: DAA therapy; early phase of infection; hepatitis C virus; modes of transmission; natural history.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Acute HCV infection diagnostic algorithm.
See this image and copyright information in PMC

References

    1. Rosen H.R. Chronic Hepatitis C Infection. N. Engl. J. Med. 2011;364:2429–2438. doi: 10.1056/NEJMcp1006613. - DOI - PubMed
    1. Manns M.P., Maasoumy B. Breakthroughs in hepatitis C research: From discovery to cure. Nat. Rev. Gastroenterol. Hepatol. 2022;19:533–550. doi: 10.1038/s41575-022-00608-8. - DOI - PMC - PubMed
    1. The Polaris Observatory HCV Collaborators Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: A modelling study. Lancet Gastroenterol. Hepatol. 2022;7:396–415. doi: 10.1016/S2468-1253(21)00472-6. - DOI - PubMed
    1. WHO . Global Health Sector Strategies on, Respectively, HIV, Viral Hepatitis and Sexually Transmitted Infections for the Period 2022–2030. World Health Organization; Geneva, Switzerland: 2022.
    1. Centers for Disease Control and Prevention Viral Hepatitis Surveillance Report. [(accessed on 3 April 2024)];2022 Available online: https://www.cdc.gov/hepatitis/statistics/2022surveillance/hepatitis-c.ht....

Substances

LinkOut - more resources